Treatment of pain using placental stem cells
US11090339B2 · kind B2 · utility
0Cited by
211References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 5, 2019 |
| Grant date | Aug 17, 2021 |
| Priority date | — |
| Expiry date | Aug 5, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N5/0668
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are methods of treatment of an individual having pain, e.g., neuropathic pain, comprising administering to the individual a therapeutically effective amount of tissue culture plastic adherent placental stem cells (PDAC™).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.